These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28641506)

  • 21. MicroPET/SPECT/CT imaging of small animal models of disease.
    Koba W; Jelicks LA; Fine EJ
    Am J Pathol; 2013 Feb; 182(2):319-24. PubMed ID: 23219729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomedical imaging in the safety evaluation of new drugs.
    Wang YX; Yan SX
    Lab Anim; 2008 Oct; 42(4):433-41. PubMed ID: 18782821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of advanced cardiac imaging methods in coronary artery disease].
    Kiraç S
    Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications for preclinical PET/MRI.
    Judenhofer MS; Cherry SR
    Semin Nucl Med; 2013 Jan; 43(1):19-29. PubMed ID: 23178086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compact Magnetic Resonance Imaging Systems-Novel Cost-Effective Tools for Preclinical Drug Safety and Efficacy Evaluation.
    Ramot Y; Schiffenbauer YS; Maronpot R; Nyska A
    Toxicol Sci; 2017 May; 157(1):3-7. PubMed ID: 28329801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomic pathology data generation in preclinical toxicology evaluation: Troubleshooting and risk management for toxicologists.
    Neef N; McInnes E
    Toxicol Lett; 2019 Oct; 314():164-171. PubMed ID: 31330168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep Learning Approaches and Applications in Toxicologic Histopathology: Current Status and Future Perspectives.
    Mehrvar S; Himmel LE; Babburi P; Goldberg AL; Guffroy M; Janardhan K; Krempley AL; Bawa B
    J Pathol Inform; 2021; 12():42. PubMed ID: 34881097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
    Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
    J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix-assisted laser desorption ionization imaging mass spectrometry detection of a magnetic resonance imaging contrast agent in mouse liver.
    Acquadro E; Cabella C; Ghiani S; Miragoli L; Bucci EM; Corpillo D
    Anal Chem; 2009 Apr; 81(7):2779-84. PubMed ID: 19281170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALBIRA: a small animal PET∕SPECT∕CT imaging system.
    Sánchez F; Orero A; Soriano A; Correcher C; Conde P; González A; Hernández L; Moliner L; Rodríguez-Alvarez MJ; Vidal LF; Benlloch JM; Chapman SE; Leevy WM
    Med Phys; 2013 May; 40(5):051906. PubMed ID: 23635276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opinion on Current Use of Non-Blinded Versus Blinded Histopathologic Evaluation in Animal Toxicity Studies.
    Bolon B; Caverly Rae JM; Colman K; Francke S; Jensen K; Keane K; McInnes EF; Nakano-Ito K; Perry R; Polack E; Regan KS; Romeike A; Young JK; Galbreath EJ
    Toxicol Pathol; 2020 Jun; 48(4):549-559. PubMed ID: 32347786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET/MRI: challenges, solutions and perspectives.
    Herzog H
    Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations for conducting imaging studies in support of developmental toxicology studies for regulatory submission.
    Johnson CA; Winkelmann CT; Wise LD
    Reprod Toxicol; 2014 Sep; 48():41-3. PubMed ID: 24863470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrid imaging technology: from dreams and vision to clinical devices.
    Patton JA; Townsend DW; Hutton BF
    Semin Nucl Med; 2009 Jul; 39(4):247-63. PubMed ID: 19497402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hybrid imaging: clinical evidence, opportunities].
    Trencsényi G; Barna SK; Garai I
    Orv Hetil; 2015 Dec; 156(52):2110-5. PubMed ID: 26686747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.